Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Stock Has Consensus Target Price of $4.60 According to Analysts

Summary by MarketBeat
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and five have issued a buy

1 Articles

MarketBeatMarketBeat
Center

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Stock Has Consensus Target Price of $4.60 According to Analysts

ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has been assigned an average rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and five have issued a buy

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, October 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Burlingame icon

Burlingame

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal